English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Structural Characterization of Amorfrutins Bound to the Peroxisome Proliferator-Activated Receptor gamma

de Groot, J. C., Weidner, C., Krausze, J., Kawamoto, K., Schroeder, F. C., Sauer, S., et al. (2013). Structural Characterization of Amorfrutins Bound to the Peroxisome Proliferator-Activated Receptor gamma. Journal of Medicinal Chemistry, 56(4), 1535-1543. doi:10.1021/jm3013272.

Item is

Files

show Files
hide Files
:
de Groot.pdf (Publisher version), 5MB
Name:
de Groot.pdf
Description:
-
OA-Status:
Visibility:
Public
MIME-Type / Checksum:
application/pdf / [MD5]
Technical Metadata:
Copyright Date:
-
Copyright Info:
© 2013 American Chemical Society
License:
-

Locators

show

Creators

show
hide
 Creators:
de Groot, J. C., Author
Weidner, C.1, Author           
Krausze, J., Author
Kawamoto, K., Author
Schroeder, F. C., Author
Sauer, S.1, Author           
Büssow, K., Author
Affiliations:
1Nutrigenomics and Gene Regulation (Sascha Sauer), Independent Junior Research Groups (OWL), Max Planck Institute for Molecular Genetics, Max Planck Society, ou_1479662              

Content

show
hide
Free keywords: -
 Abstract: Amorfrutins are a family of natural products with high affinity to the peroxisome proliferator-activated receptor gamma (PPARgamma), a nuclear receptor regulating lipid and glucose metabolism. The PPARgamma agonist rosiglitazone increases insulin sensitivity and is effective against type II diabetes but has severe adverse effects including weight gain. Amorfrutins improve insulin sensitivity and dyslipidemia but do not enhance undesired fat storage. They bear potential as therapeutics or prophylactic dietary supplements. We identified amorfrutin B as a novel partial agonist of PPARgamma with a considerably higher affinity than that of previously reported amorfrutins, similar to that of rosiglitazone. Crystal structures reveal the geranyl side chain of amorfrutin B as the cause of its particularly high affinity. Typical for partial agonists, amorfrutins 1, 2, and B bind helix H3 and the beta-sheet of PPARgamma but not helix H12.

Details

show
hide
Language(s): eng - English
 Dates: 2013-02-062013-02-28
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: DOI: 10.1021/jm3013272
ISSN: 1520-4804 (Electronic)0022-2623 (Print)
URI: http://www.ncbi.nlm.nih.gov/pubmed/23286787
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Journal of Medicinal Chemistry
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: Washington DC : ACS Publications
Pages: - Volume / Issue: 56 (4) Sequence Number: - Start / End Page: 1535 - 1543 Identifier: ISSN: 0022-2623
CoNE: https://pure.mpg.de/cone/journals/resource/110992357271168